Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe

Darmstadt, Germany, July 16, 2026 (GLOBE NEWSWIRE) -- Merck, a leading science and technology company, today opened a new €25 million BioReliance ® testing facility at its global headquarters in Darmstadt, Germany. The facility expands access to commercial drug substance and drug product release testing as well as stability testing for biopharmaceutical companies developing and commercializing therapies in Europe.